Evaluation of the Metabolic Surgery Technique for Glycemic Improvement in Type 2 Diabetes

NCT ID: NCT06600555

Last Updated: 2024-09-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-07-03

Study Completion Date

2032-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Surgery is one of the management options for type 2 diabetes in patients with moderate obesity. This is a recent option because it has been part of the recommendations since October 2022.

The possible surgical techniques are the same as those for bariatric surgery:

* Sleeve,
* Bypass,
* Gastric band, but the main goal is not weight loss, it is remission of type 2 diabetes. It is called metabolic surgery.

The ring technique (gastroplasty) is practiced less and less in France because it is less effective in weight loss and is responsible for major discomfort.

Currently, metabolic surgery is one of the recommendations but no study has compared the effectiveness of the techniques with each other. One or other of the techniques can be chosen according to the preferences of the surgeon, the patient, the center, etc. but this choice is not made objectively, in the absence of comparative data.

This study would like to follow up on patients for whom metabolic surgery has been proposed by the doctor,.

If the surgery is accepted, this study would like to improve knowledge of the effectiveness of the different techniques, and thus demonstrate which metabolic surgery technique is preferred in terms of effectiveness and safety.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus, Type 2 Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

metabolic surgery with SLEEVE technique

Group Type EXPERIMENTAL

metabolic surgery with SLEEVE technique

Intervention Type PROCEDURE

metabolic surgery with SLEEVE technique

metabolic surgery with BY-PASS technique

Group Type EXPERIMENTAL

metabolic surgery with BY-PASS technique

Intervention Type PROCEDURE

metabolic surgery with BY-PASS technique

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

metabolic surgery with SLEEVE technique

metabolic surgery with SLEEVE technique

Intervention Type PROCEDURE

metabolic surgery with BY-PASS technique

metabolic surgery with BY-PASS technique

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adult patient and ≤ 65 years old
* T2D patient, with individualized glycemic objectives not achieved, despite medical care, in particular diabetological and nutritional, also including adapted physical activity, well conducted according to current good practice recommendations, for at least twelve months
* BMI between 30 and 34.9 kg/m²
* patient well informed beforehand about metabolic surgery and the study
* multidisciplinary evaluation (including a diabetologist) and decision on medical treatment by CM (date prior to inclusion)
* medical assessment of an acceptable surgical risk
* patient affiliated to or beneficiary of a social security system
* patient having freely signed the written informed consent

Exclusion Criteria

* severe cognitive or mental disorders
* severe and unstabilized eating behavior disorders
* dependence on alcohol and licit and illicit psychoactive substances
* illnesses endangering life in the short and medium term
* contraindications to general anesthesia
* absence of identified prior medical care and foreseeable inability of the patient to participate in lifelong medical monitoring
* history of bariatric surgery
* pregnant or breastfeeding woman, or having a very long-term pregnancy plan short term (\< 2 years)
* adult patient under guardianship or curatorship
* patient deprived of liberty or under judicial decision
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Médipôle Lyon-Villeurbanne

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medipole Lyon Villeurbanne

Villeurbanne, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

laetitia paradisi, Dr

Role: CONTACT

0033481655296

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

laetitia paradisi

Role: primary

0033481655296

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CHANGE metabolic surgery

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.